about
Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a Naturally Infected PatientChronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte SubsetsProfile of central and effector memory T cells in the progression of chronic human chagas diseasePlasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites.Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.Plasma cytokine expression is associated with cardiac morbidity in chagas disease.Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular functionMulticomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas diseaseCXCL-16, IL-17, and bone morphogenetic protein 2 (BMP-2) are associated with overweight and obesity conditions in middle-aged and elderly womenIL-10 and TGF-β unbalanced levels in neutrophils contribute to increase inflammatory cytokine expression in childhood obesity.Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events.Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients.Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.Profile of natural killer cells after a previous natural Vaccinia virus infection in an in vitro viral re-exposure.Mapping of the conserved antigenic domains shared between potato apyrase and parasite ATP diphosphohydrolases: potential application in human parasitic diseases.Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.Correction for Fares et al., Matrix Metalloproteinases 2 and 9 Are Differentially Expressed in Patients with Indeterminate and Cardiac Clinical Forms of Chagas Disease.Distinct Trypanosoma cruzi isolates induce activation and apoptosis of human neutrophils.Regulatory T cells: Friends or foe in human Mycobacterium leprae infection?Comparative analysis of cell phenotypes in different severe clinical forms of Chagas' disease.Human immune response to triatomine embryo extract.Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas diseaseHuman CD8 T-cell activation in acute and chronic chikungunya infectionMMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas diseaseAn overview about DNA methylation in childhood obesity: Characteristics of the studies and main findings
P50
Q21558605-9A10C3FB-9658-4873-A600-25F2F84C9778Q28555065-0ACFD844-7BF0-4BE7-9806-639B3E117B09Q33501719-79ED9B8D-CB96-43F5-B426-25FD5FDC6E59Q33540173-E7690E4A-2565-4E77-946A-BA35B0A51090Q34194841-2AD73C92-9ED0-4343-A10E-04C5F8BEED7AQ35112727-418126DF-4F9F-4EC5-8D71-BF24389B5B7AQ36258684-17607009-905B-425D-A235-97C057A83B06Q36302693-3CEF0DE8-A65D-488C-8E6E-9F5D159C75ACQ37220949-C2040159-BF71-4D53-9FBF-5FF39AE56951Q37264609-2C28D056-D7F7-43E4-B619-25ED4EF95759Q37693965-5D292844-C8C6-436A-8131-DFFAC2AA79CBQ38666310-5C9EC909-0C66-4BB0-9286-72C6461FE991Q38930514-41F750D9-CBF3-4E21-A6EB-D42F2FB1475EQ38934021-B57DB0A3-5C09-4AE2-B7F5-6E6A1400E72BQ39329438-A1925B12-DE31-4955-B02F-646B147675FDQ42236852-39CAA680-292E-4289-AA31-3370C60913FCQ42661146-2A633EF2-D032-40DE-8D6C-FF66E01B06DBQ43481047-549FD76E-5339-4956-BFEA-6C52F9495EF9Q45593876-C58E0B6C-503B-48CD-8923-136FA1E20DD6Q47143773-1E9264FF-3567-419B-83D1-B6499CC910CFQ47153536-EC3A58FA-912D-4521-B8DE-82A742427F6AQ47577197-C4ACCA13-19C8-4774-ACD6-E70C6D2CDE8BQ50958145-DD696702-FCD1-40DD-9A12-1758C45CBE11Q52552010-019790C4-BD92-47F0-A128-629666A01EE2Q56901414-1A76A41C-CF0C-4E66-8EC9-7F060C013A03Q59354717-A1CF8639-8E90-44CC-A2D2-A50D6A7F0362Q90441689-9AC34507-0E0C-4FBA-8619-FFFC9B24108BQ91221463-E1DFF485-B225-4DE4-B8E8-CFE27BC6551A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8332-2907
@en
name
Juliana A Gomes
@ast
Juliana A Gomes
@en
Juliana A Gomes
@es
Juliana A Gomes
@nl
type
label
Juliana A Gomes
@ast
Juliana A Gomes
@en
Juliana A Gomes
@es
Juliana A Gomes
@nl
prefLabel
Juliana A Gomes
@ast
Juliana A Gomes
@en
Juliana A Gomes
@es
Juliana A Gomes
@nl
P106
P1153
36770272000
P21
P31
P496
0000-0002-8332-2907